Kineta Gets $1M NIH Contract Extension

Xconomy Seattle — 

Kineta, the Seattle-based drug developer, said today it has received a $1 million contract extension from the National Institutes of Health to mine existing computer databases to find new drug targets and candidates. The first part of the contract was designed to set up computational infrastructure for the project, which involves collaborators at the University of Washington, UC Irvine, University of Oregon, and University of Utah. The project is focused on five disease categories, Kineta said, including cardiovascular, neurological, infectious disease, metabolic disorders, and autoimmunity.